Yitian Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yitian Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Amine Abdelkader Kamen
Department of Bioengineering McGill University Montreal Canada
1 shared publication - Ayyappasamy Sudalaiyadum Perumal
Department of Bioengineering, Faculty of Engineering, McGill University, Montreal, Québec, H3A 0E9, Canada
1 shared publication - Earu Banoth
National Institute of Technology Rourkela
1 shared publication - Gabriel Linaje-Ferrel
Department of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0C3, Canada
1 shared publication - Juan Manuel Rocha Angel
Department of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0C3, Canada
1 shared publication - Naresh Yandrapalli
Department of Synthetic Biology, University of Saarland, Saarbrücken, Germany
1 shared publication
Latest Publications
- Open Access
- 26 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (5) , 527
Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications
Lipid nanoparticles (LNPs) have become the cornerstone of nucleic acid delivery platforms, particularly in RNA-based vaccines and therapeutics. However, the conventional methods of LNP production, which are primarily reliant on microfluidic mixing of aqueous and organic solvent phases, pose limitations in terms of mRNA stability, residual organic contamination, scalability, cost, and environmental impact. These limitations prompted a renewed search for non-conventional strategies with the promise of improving mRNA-LNP encapsulation approaches. These emerging approaches aim to address key bottlenecks, including mRNA hydrolysis-driven degradation, high production losses, and complex downstream purification. Moreover, the ability to decouple LNP synthesis from mRNA encapsulation could enable streamlined, modular manufacturing workflows and customizable payload delivery, including single- or multiple-mRNA payloads, thereby expanding the therapeutic scope of LNPs. This review offers an early insight into the design principles and scalability potential of emerging non-conventional LNP encapsulation approaches, including solvent-free and microfluidics-free methodologies, and pre-built LNP workflows. We also examine trends in emerging LNP encapsulation tools, including high-shear mixing, sonication, membrane contraction, and other approaches. Finally, we extrapolate the suitability of the methods for scale-up approaches and their economic implications based on the process information.
- 26 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (5) , 527
Open AccessEmerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications
Lipid nanoparticles (LNPs) have become the cornerstone of nucleic acid delivery platforms, particularly in RNA-based vaccines and therapeutics. However, the conventional methods of LNP production, which are primarily reliant on microfluidic mixing of aqueous and organic solvent phases, pose limitations in terms of mRNA stability, residual organic contamination, scalability, cost, and environmental impact. These limitations prompted a renewed search for non-conventional strategies with the promise of improving mRNA-LNP encapsulation approaches. These emerging approaches aim to address key bottlenecks, including mRNA hydrolysis-driven degradation, high production losses, and complex downstream purification. Moreover, the ability to decouple LNP synthesis from mRNA encapsulation could enable streamlined, modular manufacturing workflows and customizable payload delivery, including single- or multiple-mRNA payloads, thereby expanding the therapeutic scope of LNPs. This review offers an early insight into the design principles and scalability potential of emerging non-conventional LNP encapsulation approaches, including solvent-free and microfluidics-free methodologies, and pre-built LNP workflows. We also examine trends in emerging LNP encapsulation tools, including high-shear mixing, sonication, membrane contraction, and other approaches. Finally, we extrapolate the suitability of the methods for scale-up approaches and their economic implications based on the process information.